UNSPSC 51141576: Valproate pivoxil

This classification denotes an anticonvulsant agent with the molecular formula C14H26O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9F5A05A29T, chemically known as hydroxymethyl 2-propylvalerate, pivalate but generally known as valproate pivoxil, which bears US NIH Compound Identifier 71160. European Medicines Agency schedules Valproate pivoxil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00013MIG. The term VALPROATE PIVOXIL is an International Non-Proprietary Name.

Most nations schedule valproate pivoxil under HS 29159080 and SITC 51377. As of Q4 2014, VALPROATE PIVOXIL remains the US FDA Preferred Term for this commodity. Valproate pivoxil bears US NLM identifiers UMLS ID C2349103 and NCI Concept Code C72875. SMILES: O(C(=O)C(CCC)CCC)COC(=O)C(C)(C)C.

UNSPSC 51141576 Valproate pivoxil is a Commodity code that nominally refers to a specific anticonvulsant pharmaceutical, but recent state and local procurement activity under this code shows no alignment with that product scope. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits naloxone and safe drug deactivation systems for community health support, not valproate pivoxil or any anticonvulsant medication. The mismatch suggests a coding error in the county's procurement system rather than genuine market activity in valproate pivoxil procurement at the state and local level.

No recent state and local contract opportunities for valproate pivoxil itself appear in the available record. The Seminole County solicitation, while tagged to this code, is materially unrelated to the code's nominal pharmaceutical scope and does not provide representative activity for valproate pivoxil business development purposes.